
### [NCIT:C4456](http://purl.obolibrary.org/obo/NCIT_C4456)
**Label:** Malignant Mesothelioma

**Subclasses:** [NCIT:C136399](http://purl.obolibrary.org/obo/NCIT_C136399) (Pleural Malignant Mesothelioma by AJCC v8 Stage), [NCIT:C7985](http://purl.obolibrary.org/obo/NCIT_C7985) (Epithelioid Mesothelioma), [NCIT:C7866](http://purl.obolibrary.org/obo/NCIT_C7866) (Recurrent Malignant Mesothelioma), [NCIT:C45663](http://purl.obolibrary.org/obo/NCIT_C45663) (Pleural Sarcomatoid Mesothelioma), [NCIT:C45662](http://purl.obolibrary.org/obo/NCIT_C45662) (Pleural Epithelioid Mesothelioma), [NCIT:C45665](http://purl.obolibrary.org/obo/NCIT_C45665) (Pleural Biphasic Mesothelioma), [NCIT:C45664](http://purl.obolibrary.org/obo/NCIT_C45664) (Pleural Desmoplastic Mesothelioma), [NCIT:C45666](http://purl.obolibrary.org/obo/NCIT_C45666) (Localized Pleural Malignant Mesothelioma), [NCIT:C136374](http://purl.obolibrary.org/obo/NCIT_C136374) (Pleural Malignant Mesothelioma by AJCC v7 Stage), [NCIT:C9350](http://purl.obolibrary.org/obo/NCIT_C9350) (Peritoneal Malignant Mesothelioma), [NCIT:C40444](http://purl.obolibrary.org/obo/NCIT_C40444) (Ovarian Malignant Mesothelioma), [NCIT:C6648](http://purl.obolibrary.org/obo/NCIT_C6648) (Stage III Pleural Malignant Mesothelioma AJCC v7), [NCIT:C6747](http://purl.obolibrary.org/obo/NCIT_C6747) (Desmoplastic Mesothelioma), [NCIT:C136403](http://purl.obolibrary.org/obo/NCIT_C136403) (Stage III Pleural Malignant Mesothelioma AJCC v8), [NCIT:C8707](http://purl.obolibrary.org/obo/NCIT_C8707) (Recurrent Pleural Malignant Mesothelioma), [NCIT:C6647](http://purl.obolibrary.org/obo/NCIT_C6647) (Stage II Pleural Malignant Mesothelioma AJCC v7), [NCIT:C8705](http://purl.obolibrary.org/obo/NCIT_C8705) (Recurrent Peritoneal Malignant Mesothelioma), [NCIT:C136406](http://purl.obolibrary.org/obo/NCIT_C136406) (Stage IV Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6649](http://purl.obolibrary.org/obo/NCIT_C6649) (Stage IV Pleural Malignant Mesothelioma AJCC v7), [NCIT:C136400](http://purl.obolibrary.org/obo/NCIT_C136400) (Stage I Pleural Malignant Mesothelioma AJCC v8), [NCIT:C6646](http://purl.obolibrary.org/obo/NCIT_C6646) (Stage I Pleural Malignant Mesothelioma AJCC v7), [NCIT:C9239](http://purl.obolibrary.org/obo/NCIT_C9239) (Localized Malignant Mesothelioma), [NCIT:C136402](http://purl.obolibrary.org/obo/NCIT_C136402) (Stage II Pleural Malignant Mesothelioma AJCC v8), [NCIT:C7376](http://purl.obolibrary.org/obo/NCIT_C7376) (Pleural Malignant Mesothelioma), [NCIT:C27926](http://purl.obolibrary.org/obo/NCIT_C27926) (Asbestos-Related Malignant Mesothelioma), [NCIT:C7631](http://purl.obolibrary.org/obo/NCIT_C7631) (Pericardial Malignant Mesothelioma), [NCIT:C4282](http://purl.obolibrary.org/obo/NCIT_C4282) (Biphasic Mesothelioma), [NCIT:C45655](http://purl.obolibrary.org/obo/NCIT_C45655) (Sarcomatoid Mesothelioma), [NCIT:C8420](http://purl.obolibrary.org/obo/NCIT_C8420) (Diffuse Malignant Mesothelioma), [NCIT:C9253](http://purl.obolibrary.org/obo/NCIT_C9253) (Recurrent Pericardial Malignant Mesothelioma), 

**Class expressions from DL-Learner:**

- Thing 52.12%
- [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 45.91%
- [NCIT:C36829](http://purl.obolibrary.org/obo/NCIT_C36829) (Abnormal Mesothelial Cell) 45.91%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) 42.50%
- [NCIT:C12917](http://purl.obolibrary.org/obo/NCIT_C12917) (Malignant Cell) and [NCIT:C41605](http://purl.obolibrary.org/obo/NCIT_C41605) (Neoplastic Mesothelial Cell) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40311](http://purl.obolibrary.org/obo/NCIT_C40311) (Vulvar Syringoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40309](http://purl.obolibrary.org/obo/NCIT_C40309) (Vulvar Sebaceous Carcinoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40308](http://purl.obolibrary.org/obo/NCIT_C40308) (Vulvar Apocrine Adenocarcinoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40307](http://purl.obolibrary.org/obo/NCIT_C40307) (Vulvar Clear Cell Hidradenocarcinoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40306](http://purl.obolibrary.org/obo/NCIT_C40306) (Vulvar Eccrine Porocarcinoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40301](http://purl.obolibrary.org/obo/NCIT_C40301) (Adenoma of Minor Vestibular Glands))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40299](http://purl.obolibrary.org/obo/NCIT_C40299) (Bartholin Gland Adenoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40298](http://purl.obolibrary.org/obo/NCIT_C40298) (Bartholin Gland Small Cell Carcinoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40297](http://purl.obolibrary.org/obo/NCIT_C40297) (Bartholin Gland Transitional Cell Carcinoma))) 42.50%
- [NCIT:C36831](http://purl.obolibrary.org/obo/NCIT_C36831) (Malignant Mesothelial Cell) and (not ([NCIT:C40296](http://purl.obolibrary.org/obo/NCIT_C40296) (Bartholin Gland Adenosquamous Carcinoma))) 42.50%


